Miroslav Korbeľ

Miroslav Korbeľ

Auto-generated profile, based on publicly available information

Miroslav Korbeľ

1st Department of Gynaecology and Obstetrics of Faculty of Medicine, Comenius University Bratislava, Bratislava, Slovakia

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2021 in Česká gynekologie
Verified
Journal Article
Closed access
MKMiroslav Korbeľ
Miroslav Korbeľ
JŠJozef Šufliarsky
Jozef Šufliarsky
ĽDĽudovít Danihel
Ľudovít Danihel
ZNZuzana Nižňanská
Zuzana Nižňanská
Objective: Gestational trophoblastic neoplasia epidemiology and treatment results in the Slovak Republic in the years 1993-2017. Methods: Retrospective analysis results of gestational trophoblastic neoplasia treatment in the Centre for gestational trophoblastic disease in the Slovak Republic in Bratislava in the years 1993-2017 according to prognostic scoring and staging system FIGO/WHO (International Federation of Gynecology and Obstetrics/World Health Organization). Results: The Centre for Gestational Trophoblastic Disease was created in the Slovak Republic in the year 1993, after the split of former Czechoslovakia. A total of 100 patients with gestational trophoblastic neoplasia were treated in this Centre in the years 1993-2017. According to prognostic scoring and staging system FIGO/WHO, 74% patients were at a low risk and 26% of patients were at a high-risk of gestational trophoblastic neoplasia. There were 56, 2, 32 and 10% patients in stages I, II, III, and IV, respectively. The total curability and mortality rates were 96 and 4%, respectively. The curability rate 100% was achieved in stages I-III and in all placental site trophoblastic tumours, and the curability rate 60% was achieved in stage IV. In the years 1993 -2017, the incidences were 1 in 59,315 pregnancies and 1 in 42,299 deliveries for choriocarcinoma, 1 in 489,348 pregnancies and 1 in 348,965 deliveries for placental site trophoblastic tumours, 1 in 139,814 pregnancies and 1 in 99,704 deliveries for invasive mole, and 1 in 39,947 pregnancies and 1 in 28,487 deliveries for persistent gestational trophoblastic neoplasia. In the Czech Republic in the same period of time, there were treated 281 (301) patients with the curability rate 98.6% (98.7%). Conclusion: The results of the treatment of gestational trophoblastic neoplasia in the Slovak Republic are comparable with those achieved by leading centers specialized for the treatment of this disease in Europe and in the world. Early detection and centralisation of the treatment are crucial points for successful treatment, as the high curability rate of gestational trophoblastic neoplasia is achieved by effective therapy.

24 July 2023 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
AAAdam Adamec
Adam Adamec
MVMária Vargová
Mária Vargová
AKAlexandra Krištúfková
Alexandra Krištúfková
ZNZuzana Niznanska
Zuzana Niznanska
MKMiroslav Korbel
Miroslav Korbel

1 January 2019
Verified
Journal Article
Closed access
MKM. Korbel
M. Korbel
AKA. Kristufkova
A. Kristufkova
JDJ. Danis
J. Danis
BNB. Nemethova
B. Nemethova
PKP. Kascak
P. Kascak
ZNZ. Niznonska
Z. Niznonska

29 August 2023 in Česká gynekologie
Verified
Journal Article
Closed access
MVMária Vargová
Mária Vargová
AAAdam Adamec
Adam Adamec
DKDominika Kotríková
Dominika Kotríková
LMLiam McCullough
Liam McCullough
DKDiana Kanásová
Diana Kanásová
MKMiroslav Korbeľ
Miroslav Korbeľ
Objective: Analysis of life-threatening maternal morbidities, the condition of which required subsequent treatment in Intensive Care Units (ICU) in the Slovak Republic in the years 2012–2020. Methodology: Retrospective analysis of 655 identified cases of mothers admitted to the intensive care units out of 436,136 births. The reasons for the transport were divided into nine categories: peripartum bleeding, hypertensive diseases, thromboembolism, cardiovascular diseases, sepsis/severe infections, metabolic diseases, complications of anaesthesiology, gastroenterological problems and others. Results: The total incidence of admission to the intensive care units in the observed period was 1.5 per 1,000 births, but for mothers of Roma nationality it was 8.8 per 1,000 births. The average age of mothers was 30.7 years, while 29.7% were over 35 years old. Overweight and obesity was present by 70.4% of mothers. The most common reason for transport to the ICU (49.3%) was severe postpartum hemorrhage. The second most common cause (26.0%) was hypertensive diseases (preeclampsia, eclampsia and HELLP syndrome). The third most common cause (4.9%) was sepsis and severe maternal infections. The mortality rate of mothers admitted to the ICU was 2.3% and infant mortality of these mothers was 8.7%. Conclusion: The incidence of admission of mothers to the ICU in the monitored years was 1.5 per 1,000 births, which in international comparison ranks Slovakia among countries with a lower incidence. Key words: severe acute maternal morbidity – mother admission to the intensive care unit

29 October 2025 in Bratislava Medical Journal
Verified
Journal Article
Open access
PDF file
MVMária Vargová
Mária Vargová
AKAlexandra Krištúfková
Alexandra Krištúfková
AAAdam Adamec
Adam Adamec
JDJakub Daniš
Jakub Daniš
LMLiam McCullough
Liam McCullough
MKMiroslav Korbeľ
Miroslav Korbeľ
Objective: Analysis of life-threatening maternal morbidities and their subsequent treatment in intensive care units in Slovakia during the years 2012–2021. Material and Methods: A descriptive, population-based study of 747 cases of mothers admitted to intensive care units (ICU). The reasons for admission were divided into nine categories: peripartum haemorrhage, hypertensive disorders, thromboembolism, cardiovascular diseases, sepsis-severe infections, metabolic diseases, anaesthesia-related complications, gastrointestinal disorders, and others. Results: The overall incidence of ICU admission was 1.4 per 1000 births. The most common reasons for ICU admission were severe postpartum haemorrhage (49.1%), hypertensive disorders (25.3%) and sepsis or severe infections (4.7%). Age-specific incidence ranged from 1.1 in the 20–29 age group to 3.5 per 1000 births in women aged 40 and over. Incidence of ICU admission after caesarean section (3.85) was 9.4-fold higher than after vaginal delivery (0.34). The higher proportion of ICU admissions occurred after the 37th gestational week (51.5%), but the incidence before the 37th weeks was 11.7-fold higher than after the 37th week. Almost one third of ICU admitted mothers were overweight (19.5%) or obese (14.4%). The incidence of ICU admission among mothers of Roma nationality (10.3) was 8.6 time higher than non-Roma nationality (1.2). Maternal mortality among ICU-admitted mothers was 2.7% and perinatal mortality of their newborns was 9.5%. Conclusion: The incidence of maternal ICU admissions in Slovakia ranks among the lowest globally. However, significant risk factors such as advanced maternal age, high BMI and cesarean section delivery highlight the need for targeted interventions. Severe postpartum haemorrhage, hypertensive disorders and sepsis remain the leading cause of ICU admissions.

26 April 2022 in Česká gynekologie
Verified
Journal Article
Closed access
MKMiroslav Korbeľ
Miroslav Korbeľ
AKAlexandra Krištúfková
Alexandra Krištúfková
JDJakub Daniš
Jakub Daniš
AAAdam Adamec
Adam Adamec
MVMária Vargová
Mária Vargová
ZNZuzana Niznanska
Zuzana Niznanska
Objective: Analysis of maternal morbidity in the Slovak Republic in the years 2012–2018. Methods: The analysis of selected maternal morbidity data prospectively collected in the years 2012–2018 from all obstetric units in the Slovak Republic. Results: In the years 2012–2018, incidence of severe peripartum bleeding was 2.17, peripartum hysterectomy was 0.89, maternal admission to intensive care units was 1.59, eclampsia was 0.21, HELLP syndrome was 0.73, abnormally invasive placentation was 0.37, uterine rupture was 0.68, severe sepsis in pregnancy and puerperium was 0.18 and nonfatal amniotic fl uid embolism was 0.027 per 1,000 births. Conclusion: Incidence of total severe acute maternal morbidity in the Slovak Republic was 6.84 per 1,000 births. In Slovak local conditions, there is still room for reduction of severe acute maternal morbidity. Key words: severe acute maternal morbidity – severe peripartum haemorrhage – peripartum hysterectomy – eclampsia – HELLP syndrome – abnormally invasive placentation – uterine rupture – sepsis – amniotic fl uid embolism – sepsis